 |
| Bioprocess Containers Market |
Bioprocess containers are vessels used to grow microbial cells or tissue cultures under controlled process conditions. These containers support cultivation, containment, and harvesting of living cells or tissues under aseptic, defined and controlled conditions. The demand for bioprocess containers is driven by their wide range of applications in monoclonal antibody production, vaccine production, gene therapy and recombinant proteins production. Bioprocess containers are available in various sizes and types like culture bags, bioreactors and liquid handling containers that allow optimum growth of cells and tissues. The growing demand for biological drugs and need for effective management of aseptic conditions is fueling the growth of the global bioprocess containers market.
Global bioprocess containers market is estimated to be valued at US$ 3.67 Bn in 2024 and is expected to exhibit a CAGR of 14.% over the forecast period of 2024 to 2031.
Key Takeaways
Key players operating in the Bioprocess Containers market are Cole-Parmer Instrument Company, LLC., ALLpaQ Packaging Group, GE Healthcare, Merck KGaA, Thermo Fisher Scientific, Inc., Sartorius AG, Danaher, Entegris, Inc., Avantor, Inc., RIM Bio, Fenner PLC, Lonza, Saint-Gobain, Corning Incorporated. Major players are focusing on acquisitions, partnerships, and new product launches to strengthen their geographical presence and enhance their product portfolio.
The emergence of regenerative medicine and gene therapies act as a major opportunity for players in the Bioprocess Containers Market Demand. The demand for containers that effectively support scale-up of regenerative medicines and gene therapies is expected to drive future growth.
Key players are expanding globally to tap the growing demand from emerging markets like Asia Pacific and Latin America. Targeted acquisitions help them expand manufacturing facilities and commercial presence in high growth markets.
Market Drivers
Increasing demand for monoclonal antibodies and recombinant proteins: Monoclonal antibodies have wide applications in chronic disease management and cancer drugs. The requirement of optimized and controlled process environment for production of monoclonal antibodies drives the demand for bioprocess containers.
Rise in biopharmaceutical R&D expenditure: Increased R&D investment by pharmaceutical companies for development of biologics is propelling the growth of bioprocess containers market. Bioprocess containers help achieve desired process results and product specifications.
Market Restraints
High prices of single-use bioprocess containers: Single-use containers comprise major share of the bioprocess containers market owing to benefits like reduced risk of cross-contamination. However, single-use bioprocess containers come with higher prices which limits their widespread adoption.
Complex regulatory compliance for bioprocess containers: Manufacturers of bioprocess containers have to meet strict regulatory guidelines and quality standards set by regulatory bodies like U.S. FDA and EMA. Complying with complex regulations increases the overall costs.
Segment Analysis
The bioprocess containers market is dominated by single-use containers segment which holds more than 65% share. Single-use containers are preferred over re-usable containers in biopharmaceutical manufacturing as they eliminate the need for cleaning and sterilization between batches, minimizing turnaround time and risk of cross contamination. They also reduce costs associated with warehousing and maintenance of re-usable containers.
Global Analysis
The North America region is expected to maintain its dominance in the bioprocess containers market during the forecast period. This is attributed to robust pharmaceutical manufacturing activity and presence of key players in the region. The region is projected to grow at around 14% annually between 2024-2031. The Asia Pacific region is expected to witness the highest growth of over 16% CAGR owing to increasing investments in biopharmaceutical manufacturing by countries like China, India and Singapore to meet the growing demand in their large domestic pharmaceutical markets. Countries like China and India are also emerging as manufacturing hubs for global biopharmaceutical companies to outsource production, thus driving demand for bioprocess containers.
Get more insights on Bioprocess Containers Market
Comments
Post a Comment